Protagonist Therapeutics, Inc
Ticker: 1377121
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 213.48+278.7% | 56.37+1096.8% | 4.71-15.1% | 5.55-80.4% | 28.32+505.1% | 4.68+12.2% | 4.17-98.4% | 254.95 |
| Total Income | 213.48+278.7% | 56.37+1096.8% | 4.71-15.1% | 5.55-80.4% | 28.32+505.1% | 4.68+12.2% | 4.17-98.4% | 254.95 |
| EXPENSES | ||||||||
| Expenditure | 54.71-8.8% | 60.02+17.4% | 51.13+7.4% | 47.59-0.1% | 47.63+3.3% | 46.13+7.4% | 42.96-11.7% | 48.64 |
| Tax | 2.27+251.3% | -1.50 | 0.00-100.0% | 0.17 | 0.00+100.0% | -0.42+38.2% | -0.68-120.4% | 3.33 |
| PROFIT | ||||||||
| PBT | 165.11+7141.7% | 2.28+105.8% | -39.34-13.7% | -34.60-196.7% | -11.66+65.3% | -33.63-7.5% | -31.29-114.9% | 210.67 |
| Net Profit | 162.85+4208.2% | 3.78+109.6% | -39.34-13.1% | -34.77-198.2% | -11.66+64.9% | -33.21-8.5% | -30.62-114.8% | 207.34 |
| KEY METRICS | ||||||||
| OPM % | 74.37%+80.84pp | -6.47%+93.53pp | -100.00% | -100.00%-31.82pp | -68.18%+31.82pp | -100.00% | -100.00%-180.92pp | 80.92% |
| NPM % | 76.28%+69.57pp | 6.71%+106.71pp | -100.00% | -100.00%-58.85pp | -41.15%+58.85pp | -100.00% | -100.00%-181.32pp | 81.33% |
| EPS | 2.47+4016.7% | 0.06+109.7% | -0.62-12.7% | -0.55-189.5% | -0.19+64.8% | -0.54-8.0% | -0.50-114.7% | 3.41 |
Corporate Events
Board MeetingPTGX
202617Jun
Board Meeting
Protagonist Therapeutics held its 2026 Annual Meeting of Sto…
SEC Filing ↗